Seres therapeutics announces david arkowitz to join as executive vice president, chief financial officer and head of business development

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb) announced today that david arkowitz will join as executive vice president, chief financial officer (cfo) and head of business development, effective june 1, 2021. mr. arkowitz will report directly to eric shaff, president and chief executive officer of seres. “i am excited to welcome david to the seres leadership team. he is a key addition as we continue to lead the development of a potentially new class of transformativ
MCRB Ratings Summary
MCRB Quant Ranking